Keyword: BioNTech


EU and Pfizer/BioNTech Amend Vaccine Pact

30.05.2023 -

The European Commission and vaccine makers Pfizer and BioNTech have reached agreement on amending the bloc’s 2021 supply deal for the duo’s Comirnaty mRNA-based shot. The...


BioNTech and DualityBio Sign ADC Rights Deal

14.04.2023 -

German biotech and Covid vaccine maker BioNTech has sealed a major deal with Chinese biotech DualityBio to co-develop and commercialize two cancer antibody drug...


Pfizer CEO's Texts with EC Chief Trigger Lawsuit

17.02.2023 -

Two years after European Commission president Ursula von der Leyen and Pfizer CEO Albert Bourla virtually wrapped up a major order for the Covid-19 vaccine Comirnaty that...


BioNTech to Acquire all of InstaDeep

16.01.2023 -

As it continues to leverage earnings from its top-selling mRNA-based Covid vaccine to deepen its existing knowhow, Mainz, Germany-based BioNtech has announced plans to...


BioNTech to Set up Oncology Base in Taiwan

20.12.2022 -

Germany’s BioNTech said it plans to accelerate and broaden the clinical development of its cancer immunotherapy pipeline in the Asia-Pacific region by expanding its...


Pfizer Files Rebuttal of Moderna’s Patent Claim

08.12.2022 -

Faced with a lawsuit from US rival Moderna, alleging that Pfizer and its German partner BioNTech infringed one of its patent for their top-selling Covid-19 vaccine...


BioNTech Buys Novartis Singapore Plant for Asia HQ

15.11.2022 -

German Covid-19 vaccine specialist BioNTech has acquired a production facility in Singapore from Swiss drugmaker Novartis that will serve as a manufacturing base in...


Pfizer/BioNTech Bivalent Covid Booster Wins Approvals

10.11.2022 -

UK health regulator Medicines and Healthcare products Regulatory Agency (MHRA) has approved the Pfizer/BioNTech bivalent Covid-19 vaccine for use as a booster in people...